Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endonovo Therapeutics Inc (ENDV)

Endonovo Therapeutics Inc (ENDV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,141
  • Shares Outstanding, K 590,187
  • Annual Sales, $ 80 K
  • Annual Income, $ -6,440 K
  • 60-Month Beta 2.50
  • Price/Sales 86.75
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/12/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0103 +17.48%
on 07/18/19
0.0247 -51.01%
on 06/24/19
-0.0014 (-10.37%)
since 06/19/19
3-Month
0.0090 +34.44%
on 05/24/19
0.0247 -51.01%
on 06/24/19
-0.0020 (-14.18%)
since 04/18/19
52-Week
0.0090 +34.44%
on 05/24/19
0.0661 -81.69%
on 10/03/18
-0.0234 (-65.92%)
since 07/19/18

Most Recent Stories

More News
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board

via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board

via NetworkWire - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0121 (-0.82%)
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire

via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine, today announces it has selected the corporate communications...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics and Veterans Healthcare Supply Solutions Announce Distribution Agreement

Endonovo Therapeutics, Inc. (OTCQB: ENDV) and Veterans Healthcare Supply Solutions Inc. (VHSS) today announced a long-term agreement encompassing the distribution of SofPulse(R) to Veterans Administration...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board Member. Dr. McCarthy will help Endonovo continue to advance...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Announces Steven Ford as V.P. Marketing

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, Steven Ford will be joining the company as Vice President of Marketing. In his position, Mr. Ford will be responsible for growing Endonovo's...

AGN : 163.16 (+0.68%)
ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Hires David Clark as Vice President of Sales

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced veteran sales leader David Clark joined as Endonovo's Vice President of Sales. In his new position, Mr. Clark will lead the U.S. Sales Team, distributors...

ENDV : 0.0121 (-0.82%)
MDT : 100.80 (-0.53%)
Endonovo Therapeutics Hires Nevena Zubcevik of Harvard Medical School as Chief Medical Officer

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced the appointment of Nevena Zubcevik, DO, MSPT, ATC as its chief medical officer starting July 1, 2019.

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Provides Corporate Update

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announced a corporate update and business...

ENDV : 0.0121 (-0.82%)
Endonovo Therapeutics Announces Partnership with Second Hospital

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced an agreement with a nationally recognized hospital group to enhance the quality of the healthcare/patient experience...

ENDV : 0.0121 (-0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ENDV with:

Key Turning Points

2nd Resistance Point 0.0174
1st Resistance Point 0.0147
Last Price 0.0121
1st Support Level 0.0102
2nd Support Level 0.0084

See More

52-Week High 0.0661
Fibonacci 61.8% 0.0443
Fibonacci 50% 0.0376
Fibonacci 38.2% 0.0308
Last Price 0.0121
52-Week Low 0.0090

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar